Therapy Areas: AIDS & HIV
PinneyAssociates names new chief medical officer and new vice president
23 October 2018 -

PinneyAssociates, a science-based health consulting firm, has named Judy Ashworth, MD as its new chief medical officer and Bernie Simone as its new vice president, Client Strategy and Rx-to-OTC Switch (the transfer of proven prescription drugs to non-prescription status), it was reported on Monday.

Ashworth has around two decades of experience in the development of novel analgesics and abuse-deterrent formulations. While at Grunenthal GmbH, she led the clinical team during the EU and US regulatory submission and approval of tapentadol and most recently was head of its EU Innovative Medicines Unit hub in Leiden, Netherlands.

Simone has more than 30 years of experience in the OTC industry, including in Rx-to-OTC Switch, product marketing, and business development. While at Sanofi Consumer Healthcare, he led the first-in-class switch of Nasacort Allergy 24HR and the switch of Xyzal Allergy 24HR. While at Bayer, he held several positions including director roles in business development, marketing and global category management. He led high growth strategic initiatives for the Aleve and Alka-Seltzer franchises, as well as global CardioAspirin, and multiple Rx-to-OTC switch initiatives. His experience includes more than 40 therapeutic categories in OTC medicines, prescription drugs, medical devices and dietary supplements.

Login
Username:

Password: